Related Experiment Video
Updated: Mar 12, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis
Olaia Martínez-Iglesias1, David Olmeda2, Elvira Alonso-Merino1
1Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, Spain.
Abstract:
Vascular Endotelial Growth Factors C and D (VEGF-C and VEGF-D) are crucial regulators of lymphangiogenesis, a main event in the metastatic spread of breast cancer tumors. Although inhibition of lymphangiogenic gene expression might be a useful therapeutic strategy to restrict the progression of cancer, the factors involved in the transcriptional repression of these genes are still unknown. We have previously shown that Nuclear Receptor Corepressor 1 (NCoR) and the thyroid hormone receptor β1 (TRβ) inhibit tumor invasion. Here we show that these molecules repress VEGF-C and VEGF-D gene transcription in breast cancer cells, reducing lymphatic vessel density and sentinel lymph node invasion in tumor xenografts. The clinical significance of these results is stressed by the finding that NCoR and TRβ transcripts correlate negatively with those of the lymphangiogenic genes and the lymphatic vessel marker LYVE-1 in human breast tumors. Our results point to the use of NCoR and TRβ as potential biomarkers for diagnosis or prognosis in breast cancer and suggest that further studies of these molecules as potential targets for anti-lymphangiogenic therapy are warranted.
Insights
Nuclear Receptor Corepressor 1 (NCoR) and thyroid hormone receptor β1 (TRβ) repress breast cancer
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis
Background:
- Vascular Endothelial Growth Factors C and D (VEGF-C and VEGF-D) drive lymphangiogenesis and breast cancer metastasis.
- Transcriptional repressors of VEGF-C and VEGF-D are currently unknown.
- Nuclear Receptor Corepressor 1 (NCoR) and thyroid hormone receptor β1 (TRβ) were previously shown to inhibit tumor invasion.
Purpose of the Study:
- To investigate the role of NCoR and TRβ in the transcriptional repression of VEGF-C and VEGF-D in breast cancer.
- To evaluate the therapeutic potential of NCoR and TRβ in inhibiting breast cancer metastasis.
Main Methods:
- Gene transcription assays in breast cancer cells.
- Analysis of lymphatic vessel density and lymph node invasion in tumor xenografts.
- Correlation analysis of NCoR, TRβ, VEGF-C, VEGF-D, and LYVE-1 transcript levels in human breast tumors.
Main Results:
- NCoR and TRβ were found to repress VEGF-C and VEGF-D gene transcription in breast cancer cells.
- Repression by NCoR and TRβ reduced lymphatic vessel density and sentinel lymph node invasion in vivo.
- NCoR and TRβ transcript levels negatively correlated with lymphangiogenic genes and LYVE-1 in human breast tumors.
Conclusions:
- NCoR and TRβ inhibit breast cancer lymphangiogenesis and metastasis by repressing VEGF-C and VEGF-D transcription.
- NCoR and TRβ show potential as diagnostic or prognostic biomarkers for breast cancer.
- NCoR and TRβ warrant further investigation as targets for anti-lymphangiogenic therapy.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
The Nucleolus
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes

